19:00 - 20:00 CET

Thursday, 07 March 2024

Understanding hyperphagia: a root cause, recognition & burden

Join this Rhythm-sponsored webinar hearing experts explore  the role of the melanocortin-4 receptor (MC4R) pathway in hyperphagia and early-onset, severe obesity, including a patient perspective on the real-life burden of living with hyperphagia.

 

KEY TOPICS:

  • Understanding hyperphagia: pathological, insatiable hunger – What does it really mean?
  • The MC4R pathway: function, disruption and impact on hyperphagia 
  • Clinical recognition and management of hyperphagia 
  • Real-life burden and unmet needs for patients and families

     This webinar is organised and funded by Rhythm Pharmaceuticals for healthcare professionals only.

SPEAKERS:

Photo of Prof. Carel Le Roux

Prof Carel Le Roux

(Ireland)

Prof Martin Wabitsch

(Germany)

Karrie-Anne Bullimore

(United Kingdom)

REGISTER NOW

 
 

*

‡We use this information for compliance purposes to verify your eligibility to subscribe to our communications.  
*This includes Rhythm Pharmaceuticals Netherlands B.V., Rhythm Pharmaceuticals France SAS, Rhythm Pharmaceuticals Germany GmbH, Rhythm Pharmaceuticals Italy S.r.I, Rhythm Pharmaceuticals Limited (Ireland), Rhythm Pharmaceuticals Spain S.L and Rhythm Pharmaceuticals UK Limited.  Your personal data is processed in accordance with Privacy statement.